Latest filing published 21 Sept 2023 for Paratek Pharmaceuticals, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by William M. Haskel on record concern Paratek Pharmaceuticals, Inc., in the capacity of chief executive. In total, 12 filings cover trades dated from 4 February 2016 to 21 September 2023.
No open-market purchase appears, only 3 sales worth €61k. Besides market trades, the filings include 8 share grants.
The record was last updated on 21 September 2023 with a transaction in Paratek Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations